Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Effectiveness and Safety of Resolute Onyx™ and Onyx Frontier™ in Routine Clinical Practice; A Multicenter, Prospective Observational Study

NCT02593994 is registered in ClinicalTrials.gov with Seung-Jung Park as lead sponsor.

NCT NCT02593994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02593994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Effectiveness and Safety of Resolute Onyx™ and Onyx Frontier™ in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Lead sponsor
Seung-Jung Park
Phase
Observational
Overall status
Active, not recruiting
Start date
October 31, 2015
Completion date
December 31, 2031
Enrollment
4,500 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

arterial occlusive diseases, cardiovascular diseases, coronary artery disease, percutaneous transluminal angioplasty